PATENT CLAIM ANALYSIS

Application Number: 16313777
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["549", "359000"]

Abstract:
The present invention relates to pyranochromenylphenol derivatives having different efficacies depending on the direction of optical activity and a pharmaceutical composition including the same, and in the pyranochromenylphenol derivatives, an R-enantiomer has excellent anti-diabetic efficacy by suppressing a rise in blood sugar and an S-enantiomer has excellent anti-obesity efficacy by suppressing an increase in body weight.

Claim (Index 3):
The optically active pyranochromenylphenol compound, the pharmaceutically acceptable salt, or the solvate thereof of  claim 1 ,\n wherein R 1  is ethyl, n-propyl, isopropyl, n-butyl, 2-methylpropyl, n-pentyl, 2-methylbutyl, 3-methylbutyl, 2-ethylpropyl, n-hexyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, or 2-ethylbutyl; R 2  is methyl or methoxy; and R 3  and R 4  are each methyl.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 98.0
- Lexical Diversity: 1.40476
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15037230', '16339288', '15113083', '16072586', '11359657']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7514559630081588
- 35 USC 102 Novelty (BERT): 0.5454716241378097
- Combined Prediction Score: 0.7308575291211239
- Mean Citation Score: 283.7327160000001
- Max Citation Score: 396.33713
- Similarity Product: 329.102804535774

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test